Clinical Trials Browser

Solid Tumor × toripalimab × 90 days × Clear all

NCT07392736 2026-02-06

A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor